December2016
-
Over 2.6 million displaced in lake Chad Basin
Dec 11, 2016News Hour According to IOM’s first regional analysis of displacement trends in the Lake Chad Basin crisis triggered by the Boko Haram insurgency, 2,635,450 individuals are now displaced in the region, both internally and across borders... -
New humanitarian hubs set to serve millions in Northeastern Nigeria
Dec 11, 2016News Hour The humanitarian community will soon be able to better coordinate support for northeast Nigeria, where nearly seven million people are in need of life-saving assistance. This is thanks to the setting up of a... -
ADB to support development of 5 border provinces in Viet Nam
Dec 11, 2016News Hour The Asian Development Bank (ADB) has approved a $106.51 million loan to support the development of the five Viet Nam Development Triangle Area (VDTA) provinces — Binh Phuoc, Dak Lak, Dak Nong, Gia Lai,... -
Joshua to fight Klitschko in April after easy defence
Dec 11, 2016News Hour Britain’s Anthony Joshua set up an April showdown with veteran heavyweight Wladimir Klitschko on Saturday after retaining his IBF world title with a clinical third round stoppage of outclassed American Eric Molina in Manchester.... -
India’s Shami, Saha to miss final England Test
Dec 11, 2016News Hour Indian fast bowler Mohammed Shami and wicketkeeper Wriddhiman Saha will remain out of action for India’s fifth and final Test against England, the national cricket board said Sunday. The Board of Control for Cricket... -
Novartis’ Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment
Dec 11, 2016News Hour: CRYSTAL was a prospective, multicenter, 12-week, randomized, pragmatic, open-label trial. Patients were recruited into four groups according to previous medication and symptoms, and randomized to a direct switch to Seebri® Breezhaler® (glycopyrronium) 50 mcg... -
Compulsory drug detention centres ‘have no role’ in the treatment of opioid addiction
Dec 11, 2016News Hour: People with chronic opioid use disorders are more likely to relapse and do so sooner if they are treated in a compulsory drug detentioncentre rather than a voluntary drug treatment centre using methadone maintenance... -
Spinal muscular atrophy shows promising early results, prompting phase 3 clinical trial
Dec 11, 2016News Hour: A new drug for spinal muscular atrophy has shown promising early results in a phase 2 trial involving 20 babies with infantile-onset spinal muscular atrophy. The study, published in The Lancet, found that nusinersen... -
Treatment-free Remission rates are consistently above 50% regardless of reason for switch to Tasigna® from Glivec®
Dec 11, 2016News Hour: Novartis announced at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition new data from the Tasigna® (nilotinib) ENESTop Treatment-free Remission (TFR) study, which demonstrate that TFR rates are consistent among Philadelphia... -
Novartis survey uncovers real-world burden of myeloproliferative neoplasms (rare blood cancers) on daily activity and ability to work
Dec 11, 2016News Hour: Myeloproliferative neoplasms (MPNs) are a group of related and rare blood cancers in which bone marrow cells responsible for the body’s blood cells develop and function abnormally. Specific MPN conditions include myelofibrosis (MF), polycythemia...
